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______________________________________________________________________ 
Cardiac accessory β-subunits are part of macromolecular ion channel complexes. They 
can modulate electrophysiological properties of resulting ion currents and action 
potentials and are supposed to contribute to cardiac disease e.g. arrhythmias or 
Brugada syndrome. In my thesis, we characterized the functions of dipeptidyl peptidase-
like protein 10 (DPP10), a transmembrane β-subunit of cardiac Na+ and K+ channels. 
Previous studies revealed that DPP10 is expressed in human heart and acts as 
regulator of Kv channel kinetics. In electrophysiological experiments, we found that 
DPP10 modulates Ito through Kv4.3 channel complexes by accelerating current 
densities and the time course of activation, inactivation and recovery from inactivation. 
Interestingly, co-expression of DPP10 with Kv4.3 and KChIP2 in CHO cells induced a 
slowly inactivating fraction of Ito, providing evidence for a contribution of Ito on the 
sustained outward K+ current in cardiomyoctes. Until then, the sustained fraction of K+ 
currents was thought to be due to IKur. We further studied the contribution of Kv4-
mediated Ito to total K+ currents in human atrial myocytes using 4-Aminopyridine to block 
IKur in combination with Heteropoda toxin 2 to block Kv4 channels. Using this approach, 
it was possible to separate an Ito fraction of about 19% contributing to the late current 
component. These data suggest that the generation of a sustained current component 
of Ito induced by DPP10 may affect the late repolarization phase of an atrial action 
potential. To further explore the functions of DPP10, we investigated a potential 
interaction with Nav channels in cardiomyocytes. It was possible to detect DPP10 in 
human ventricles, with higher expression levels in patients with heart failure. We 
demonstrated that DPP10 affects cellular action potentials in isolated rat 
cardiomyocytes after adenoviral gene transfer indicating a reduction in Na+ current 
density. Voltage-dependent Na+ channel activation and inactivation curve was shifted to 
more positive potentials with overexpression of DPP10, resulting in enhanced 
availability of Na+ channels for activation, along with increasing window Na+ current. 
Thus, we assumed a role of DPP10 on promotion of arrhythmias via interaction with 
Nav1.5. The results of this study can help to understand the complex interaction pattern 
between Nav and Kv channels and the role of their β-subunits, especially DPP10. In 
conclusion, DPP10 was identified as a new modulator of Kv and Nav currents in the 
human heart, suggesting that this β-subunit may contributes to cardiac arrhythmias and 
might be a new therapeutic target. 
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1.1 The cardiac action potential 
 
The heart is a muscular organ, which controls blood circulation and supplies the organs 
and tissues with nutrients and oxygen. In humans and rodents, the heart is divided in 
four chambers: left and right atria as well as left and right ventricles. The heart wall 
consists of three layers: epicardium, myocardium and endocardium. Cardiac contraction 
is regulated by electrical excitation and conduction. The basis for the excitability of the 
heart is a negative resting membrane potential of myocytes mainly resulting from the 
distribution of Na+ and K+ ions between extra- and intracellular space of the cells, the 
membrane permeability for K+ at rest and the activity of Na+/K+-ATPase. The 
transmembrane action potential (AP) of each myocyte is caused by various ionic 
currents and can be divided in 5 phases (Figure 1). The phase 0 of a human AP is 
mediated by a rapid depolarization due to a large Na+ influx into the cell with a shift in 
the membrane potential to +40 mV. This phase is followed by a rapid repolarization 
(phase 1) based on an increase of conductance for K+ ions. Subsequently, a plateau 
phase (phase 2) is formed in the potential range of +20 to -20 mV caused by Ca2+ 
currents, followed by K+ currents inducing the late repolarization phase (phase 3). 
Phase 4 contributes the stable membrane potential at -70 mV until the next AP is 
elicited. 
 
Figure 1 left: The human ventricular action potential with ion currents for particular phases and their 
direction across the cell membrane, modified from [Wettwer et al. 2003]. right: Original registration of a 
whole-cell K+ current in rat cardiomyocytes indicating peak and late current component (arrows) and the 




The cardiac sodium inward current (INa) initiates the AP (phase 0). Various studies 
revealed that the major pore-forming α-subunit in human heart is the voltage-gated Na+ 
channel Nav1.5 [Abriel 2010] and the final repolarization phase of an AP is driven by 
different voltage-gated K+ currents [Wang et al. 1993; Li et al. 1996, 1996]. In particular, 
the early phase of atrial repolarization is mainly determined by the transient outward 
current Ito and the ultra-rapid current IKur. The peak current component (Figure 1) of the 
outward current was shown to represent Ito, which is mainly encoded by Kv4.3 [Kong et 
al. 1998] and the sustained current component (Ilate) is thought to be due to the ultra-
rapidly activating “delayed” rectifier IKur [Amos et al. 1996]. Various K+ currents of 
different kinetics regulate the late phase of repolarization and termination of the AP, i.e. 
rapidly and slowly activating IKr and IKs currents and inward rectifier IK1 currents [Tristani-
Firouzi et al. 2001; Tamargo et al. 2004]. 
The waveform of action potentials differs within the different regions of the mammalian 
heart, reflecting variable expression levels of the underlying ion channels in the tissues 
of atrium and ventricle. The absence of IKur in myocytes of the ventricle leads to a much 
longer action potential duration compared to the atrial AP [Nerbonne and Kass 2005; 
Grant 2009]. Marked differences were also described in epicardial and endocardial 
tissue. Ito for example is more prominent in the epicardium compared to the 
endocardium. This transmural gradient results in the typical spike- and dome 
morphology of epicardial APs [Cordeiro et al. 2016].  
 
1.2 Cardiac potassium channels 
 
Cardiac K+ channels are membrane-spanning proteins that allow the passive movement 
of K+ ions across the cell membrane along its electrochemical gradient. They regulate 
the resting membrane potential, the frequency of pacemaker cells and the shape as well 
as the duration of the cardiac APs [Tamargo et al. 2004]. In mammalian cardiac cells, 
potassium channels can be categorized as voltage-gated (Kv) and ligand-gated 
channels [Roden et al. 2002]. Within ion channel families, K+ channels show the 
greatest diversity which is reflected in the presence of more than 70 loci in the human 
genome. The family of voltage gated K+ channels is the largest class of the four major 
classes of K+ channels (Ca2+- and Na+ activated potassium channels, Inwardly rectifying 
potassium channels, Two P domain potassium channels) [Gutman et al. 2005]. To 
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distinguish between the 12 subtypes of Kv channels, a special 4 letter code 
nomenclature (KCNx) was developed.  
Kv channel α-subunits have six transmembrane-spanning segments (S1-S6) with 
cytoplasmic N- and C- terminal domains, a voltage sensor (S4) and a pore loop 
between S5 and S6 [Snyders 1999; Tamargo et al. 2004]. Four α-subunits build a homo- 
or heterotetrameric Kv channel complex [Covarrubias et al. 1991].  Whereas the T1 
tetramerization domain plays an important role for the assembly of the channel 
complex, the voltage-sensing domain mediates the opening of the channel. The 
positively charged arginine and lysine residues of the voltage sensing region can move 
through the gating canal, caused by membrane depolarization [Birnbaum et al. 2004]. 
The pore domain (P-Loop) makes up the ion channel permeability, including an ion 
selectivity filter (Figure 2). Cardiac K+ currents, especially Ito, plays a key role in phase 1 
repolarization and thereby in excitation-contraction coupling and arrhythmogenesis [Sah 
et al. 2002; Sah et al. 2003; Calloe et al. 2009]. Commonly used anti-arrhythmic drugs 
like flecainide, quinidine and propafenone are non-specific, blocking both K+ and Na+ 
currents with unwanted side effects [Tamargo et al. 2004]. 
Interestingly, reduced Ito and Kv channel expression was shown in patients with cardiac 
hypertrophy and heart failure giving evidence for Ito as a possible therapeutic target 
[Cordeiro et al. 2016]. Therefore, a specific Ito activator should allow precise effects on 
K+ outward currents in failing hearts or other cardiovascular diseases.  
 
 
Figure 2: Schematic drawing of several structural elements present in Kv4 channels [from Birnbaum et 
al. 2004], six membrane spanning domains, which includes the T1 assembly domain, the voltage sensor 




1.2.1 The Kv4.3 channel complex 
Kv4 channels are expressed at particularly high levels in the brain and heart. Four 
members of the KCND/Kv4 channel family are known, which encode the voltage-
activated (A-type) potassium current: KCND1 (Kv4.1), KCND2 (Kv4.2) and two splice 
variants of KCND3 (Kv4.3-long or Kv4.3-short). Resulting currents are designated as Ito 
in heart and as ISA (subthreshold activated) in neurons [Isbrandt et al. 2000]. The 
transient outward current Ito plays an important role for the early repolarization phase of 
cardiac action potentials. Whereas the human Ito is predominantly mediated by channels 
that are assembled from Kv4.3 subunits alone, rodent channel complexes were mainly 
assembled by heterotetrameric Kv4.2/Kv4.3 subunits [Niwa and Nerbonne 2010]. In 
humans, Kv4.2 has been detected in neurons, suggesting a role of ISA  in postsynaptic 
signal transduction and dendritic action potential propagation [Isbrandt et al. 2000; 
Jerng et al. 2005]. Kv4 channels generate rapidly inactivating currents. Two general 
inactivation mechanisms were described [Birnbaum et al. 2004]. First, the N-type, or 
“ball and chain” inactivation type, involves the N-terminal domain of the α- or β-subunit 
of the channel. This domain binds to the intracellular entrance of the pore only if the 
channel is open [Rettig et al. 1994]. The second inactivation type is the C-type and 
involves the pinching of the pore near the selectivity filter and their structural change 
[Ogielska et al. 1995; Panyi et al. 1995]. The C-type shows much slower inactivation 
kinetics compared to the N-type, indicating a coupling of both inactivation mechanisms 
during repolarization [Hoshi et al. 1991; Baukrowitz and Yellen 1995, 1995]. The peak 
current component of a total K+ outward current involved in phase 1 of a mammalian AP 
is thought to be due to Ito with its molecular constituent Kv4.3 [Amos et al. 1996]. Kv4.3 
is expressed in the atrium and ventricle, but a transmural gradient of the current from 
endocardium to epicardium shows that Ito is more prominent in epicardial 
cardiomyocytes [Cordeiro et al. 2016].  
1.2.2 Accessory β-subunits of K+ channel 
The α-subunit of K+ channels can interact with several accessory β-subunits, for 
example with K+ channel interacting protein (KChIP) on the cytosolic N-terminal part of 
the channel protein and dipeptidylpeptidase-like proteins (DPPs) as a transmembrane 
protein in the channel complex (Figure 3). Furthermore, many other β-subunits have 




Figure 3: Schematic illustration of the molecular structure of Kv4.3 channel complex. The pore-forming 
α-subunit with multiple accessory β-subunits, i.e. KChIP2 and DPPs are shown [from Niwa and 
Nerbonne 2010]. 
 
KChIPs are members of the neuronal calcium sensor subfamily of Ca2+ binding proteins 
characterized by four Ca2+-binding motifs [Ikura 1996]. The family consists of four 
different subtypes. All isoforms are expressed in the brain, KChIP2 is the only isoform 
expressed in the heart and co-immunoprecipitates with Kv4.3 and Kv4.2 [An et al. 2000; 
Bohnen et al. 2015]. KChIP2 can increase K+ current density, most likely by trafficking, 
slowing inactivation and accelerating recovery kinetics of Ito [Barghaan et al. 2008]. 
KChIP2 seems to be the major β-subunit for stabilizing Kv4.3 in the membrane, 
because in mice lacking KChIP2 Ito is dramatically reduced [Kuo et al. 2001]. KChIP2 
can also regulate the depolarizing Cav1.2 current [Grubb et al. 2015; Winther et al. 
2016], but the highest interest of KChIP2 comes from its reported downregulation in 
heart failure [Soltysinska et al. 2009], which is thought to contribute to the modified 
repolarization and altered Ca2+ handling in the disease.  
DPP6 and DPP10 belong to the prolyl-oligopeptidase family of serine proteases, with 
the best-studied member DPP4 also known as CD26. DPP4 has an exopeptidase 
activity and is of importance for the cleavage of peptide hormones for the glucose 
metabolism and a target for the treatment of type II diabetes [Zagha et al. 2005]. DPP6 
and DPP10 are predominantly expressed in the brain [Kin et al. 2001], but they were 
also detected in human heart [Radicke et al. 2005; Cotella et al. 2010]. In comparison to 






DPP4, DPP6 and DPP10 lack this enzymatic activity due to a substitution in the 
enzymatic centre [Radicke et al. 2005; Cotella et al. 2010]. The role of DPP6 and 
DPP10 is largely unknown, but the proteins gained interest as accessory β-subunits of 
Kv4.2 [Jerng et al. 2004]. DPP6 and DPP10 influence the kinetics of the Ito by 
accelerating the time course of activation, inactivation and recovery from inactivation 
[Radicke et al. 2005; Cotella et al. 2010]. Kv4-KChIP-DPP form a ternary complex in 
brain regions, including hippocampus, neocortex, cerebellum and olfactory bulb [Wang 
et al. 2015]. Here, DPP10 is implicated in neuropsychiatric diseases such as autism 
[Girirajan et al. 2013] and Alzheimer disease [Chen et al. 2014]. DPP10 was also 
detected in human atria [Cotella et al. 2010; Turnow et al. 2015], but no studies were 
known for DPP10 expressed in ventricles. Mutations of DPP6 result in enhanced 
expression, which were found in patients with idiopathic ventricular fibrillation. Here, the 
altered DPP6 expression is associated with changes in Ito properties and AP shape 
[Postema et al. 2011; Xiao et al. 2013]. Interestingly, increased DPP6 mRNA expression 
was also detected in patients with chronic heart failure [Radicke et al. 2005].  
The molecular structure of the DPP family comprises of a short N-terminal region, a 
single-transmembrane region and a large extracellular C-terminal region (Figure 3) 
including glycosylation domain [Nadal et al. 2003]. DPP6 and DPP10 have a very high 
amino acid identity by 91%. DPP10 partially overlaps of the DPP6 distribution pattern. 
Therefore, DPP6 may form a heteromultimeric complex with DPP10. [Kitazawa et al. 
2015]. DPPs bind independently from KChIPs (Figure 3), the region from the N-terminus 
to the start of the transmembrane domain of DPP10 for example plays an important role 
in binding to the S1-S2 segment of the Kv4 in complex formation [Kim et al. 2008]. 
Here, the combination of Kv4, KChIP, and DPP6/10 in the channel complex would give 
rise to further diversity of the biophysical properties and may dynamically regulate cell 
excitability [Kitazawa et al. 2015]. 
1.2.3 The Kv1.5 channel (IKur) 
Multiple channels are suggested to contribute to the total K+ outward current in human 
cardiomyocytes. Because of their overlap in time and voltage dependence, Ito and IKur 
are difficult to separate in electrophysiological experiments. The molecular correlate of 
IKur is the Kv1.5 channel protein [Eldstrom et al. 2007], which is expressed in the atrium 
of human heart [Fedida et al. 1993; Wang et al. 1993; Mays et al. 1995; Nattel et al. 
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1999]. The current is virtually absent in ventricular myocytes of most species [Ravens 
and Wettwer 2011]. Knock-down experiments with antisense oligonucleotides against 
Kv1.5 did not uncover any sensitive current in human ventricular myocytes [Feng et al. 
1997]. Nevertheless, the IKur, encoded by KCNA5 is another important atrial K+ current 
in the heart. Because of the atrium specificity, IKur is considered to be an important 
target for the treatment of atrial fibrillation [Ravens and Wettwer 2011]. While Ito is 
characterized by rapid activation as well as fast inactivation, IKur is a slowly inactivating 
current. At room temperature IKur can be regarded as a “sustained” current, however 
inactivation proceeds faster at more physiological temperature [Wang et al. 1993]. 
1.2.4 Separation of Ito and IKur in native cardiomyocytes 
In general, a biophysical characterization of multiple currents in cardiomyocytes is 
difficult. The current of interest can be characterized by its time- and voltage-
dependence due to the procedures for eliminating the underlying currents. These 
difficulties also emerge with the characterization of Ito and IKur in human atrial 
cardiomyocytes because the two currents have a similar voltage range of activation and 
IKur reveals considerable inactivation at physiological temperature [Ravens and Wettwer 
2011]. Since Ito and IKur overlap during activation in native myocytes, methods are 
needed to distinguish between the two components. This is usually done on the basis of 
different kinetic properties or by use of selective blockers. Another possibility is to clone 
individual ion channels from cardiac tissue and express them in heterologous cell 
systems to study their electrophysiological properties separately. Four Drosophila 
melanogaster subfamilies were described (Shaker, Shab, Shal, Shaw) and the first 
cloned mammalian K+ channels were related to these subfamilies, including those 
cloned from rat and human heart [Snyders 1999]. On the other hand, the characteristics 
of a native current, such as Ito are not reproducible in heterologous expression systems, 
because not all accessory β-subunits, which interact with K+ channels and modulate 
current kinetics are completely known [Nerbonne 2000]. However, comparison between 
currents of heterologous expression systems and native cardiomyocytes can help to 
elucidate the physiological mechanisms. 
A pharmacological approach to separate ionic currents is the use of selective blocker. 
To study the physiological role of Ito in human atrial myocytes, 4-Aminopyridine (4-AP) 
can be used to differentiate between Ito and IKur. It is known that 4-AP can block Kv 
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currents in a concentration-dependent manner [Bertaso et al. 2002]. Ito is sensitive to 4-
AP only in high concentrations of 2 mM, whereas IKur can be effectively blocked with 
much lower concentrations around 10 µM (Figure 4). Kv currents, especially Ito are also 
sensitive to a class of spider toxins, including Heteropoda toxin 2 (HpTx2) [Zarayskiy et 
al. 2005]. Therefore, HpTx2 and 4-AP in combination can be used to separate 
pharmacologically between Ito and IKur in native atrial cardiomyocytes.  
 
Figure 4: Effects of 2 mM and 10 µM 4-AP on K+ outward currents of human atrial myocytes. Currents 
were elicited by 200 ms depolarizing steps to +40 mV every 10 s. Experiments were performed at 37°C. 
A concentration-dependent effect of 4-AP could be observed. Peak currents were effected by high 
concentrations, whereas sustained (late) currents could be blocked by much lower concentrations of 4-
AP [from Bertaso et al. 2002]. 
 
1.3 Cardiac sodium channels 
 
Voltage-gated sodium channels (Nav channels) activate and inactivate extreme rapidly 
(within 1 to 5 ms, respectively). Activation is caused by a conformational change that 
opens the pore. Once open, the sodium channel is highly selective for Na+ ions, 
approximately 10-fold more permeant than for K+ ions and 50-fold more permeant than 
for Ca+ ions [Hille 1971, 1972]. The activation of Nav channels leads to a brief pulse of 
an inward Na+ current, which is responsible for the rapid depolarization within the 
cardiac action potential. Nav channels are expressed in mammalian ventricular and 
atrial myocytes as well as cardiac Purkinje fibers [Brown et al. 1981; Makielski et al. 
1987]. It is well known that Nav channel expressed in other excitable cells (e.g. neurons 
or muscle cells) show different biophysical and pharmacological properties compared to 
channels expressed in cardiac cells. For example, cardiac Nav channel are remarkably 
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insensitive to the channel toxin Tetrodotoxin (TTX), whereas neuronal Nav channel can 
be blocked by TTX in nanomolar ranges [Noda et al. 1989; Terlau et al. 1991]. 
1.3.1 Molecular construction of Nav1.5 channel  
In humans, Nav channels are encoded by 10 different genes. Related proteins are 
expressed in excitable tissues including heart, central nervous system (CNS), peripheral 
nervous system (PNS) and skeletal muscle. Nav1.1, 1.2, 1.4 and 1.6 are the primary 
Nav channels in the CNS, whereas Nav1.7, 1.8 and 1.9 are prominent in the PNS. 
Nav1.4 is the primary expressed sodium channel in the skeletal muscle tissue. The 
most prominent Nav channel in the heart is Nav1.5, encoded by the gene SCN5A. The 
large pore-forming α-subunit of about 220 kDa can interact with different β-subunits 
[Shy et al. 2013]. The α-subunit has four repeat domains, each containing six 
membrane-spanning regions named S1 to S6. The highly conserved S4 region acts as 
voltage sensor (Figure 5). Changes in the transmembrane voltage can stimulate this 
region to move toward the extracellular side of the cell membrane, allowing the channel 
to become permeable for ions. The region between S5 and S6 (P-loops) form the pore 




Figure 5: Schematic linear representation of the structure of voltage-gated sodium channel. The voltage 
sensor on segment 4 of each domain is marked with “+” and highlighted in grey. Extracellular loops 
between segments 5 and 6 within each domain forms the channel pore region. TTX sensitivity site is 
located in the extracellular loop of DI. Accessory transmembrane β-subunits shown on the right [from 




1.3.2 Accessory β-subunits of Na+ channel 
Functional macromolecular cardiac Nav channel complexes reflect the co-assembly of 
pore-forming α-subunits with accessory β-subunits modulating biophysical properties. 
Nav1.5 interacts with several β-subunits that regulate the channel function. They can be 
involved in anchoring or trafficking as well as modifying the channel structure. A family 
of four transmembrane Navβ-subunits are encoded in the human genome  
[Brackenbury and Isom 2011]. Navβ1 and Navβ3 are associated noncovalently with the 
α-subunit, whereas Navβ2 and Navβ4 form disulfide bonds [Morgan et al. 2000]. Navβ1 
can affect Nav1.5 channel trafficking or its anchoring to specific membrane 
compartments. Mutations in the genes coding for Nav-regulatory proteins, such as 
Navβ1 have been identified in patients with Brugada syndrome (BrS), atrial fibrillation or 
cardiac conduction disease [Deschênes and Tomaselli 2002; Shy et al. 2013]. 
Interestingly, Navβ1 not only interacts with Nav1.5, but also modulates properties of the 
transient outward K+ current Ito via interaction with its pore-forming α-subunit Kv4.3 
[Deschênes and Tomaselli 2002]. Inhibition of Navβ1 transcription in rat ventricular 
myocytes, using small interfering RNA caused reduction in expression levels of Nav1.5, 
Kv4.2 and Kv4.3 channel subunits [Deschênes et al. 2008]. Thus, Navβ1 can link Na+ 
and K+ channels to multiprotein complexes, thereby enabling the direct interaction of 
different channel classes in the heart. This hypothesis is supported by the observation 
that also a knock-down of KChIP2, using specific small interfering RNA suppressed both 
cardiac Ito and INa consistent with a functional coupling of these channels. KChIP2 is 
known to associate with and modulate the Kv4 family, but inhibition of KChIP2 
expression reduced transcript expression of Nav1.5, Navβ1, as well as Kv4.3 
[Deschênes et al. 2008]. 
1.3.3 The role of Nav1.5 in cardiac electrical disorders 
Recent studies have shown that hundreds of mutations of SCN5A can be linked to 
many cardiac diseases, including congenital, acquired long QT syndrome, Brugada 
syndrome, conduction slowing, sick sinus syndrome, atrial fibrillation and dilated 
cardiomyopathy [Wilde and Brugada 2011; Remme and Wilde 2014]. This list of 
diseases underlies the important role of Nav1.5 in the physiology of the heart and raises 
new questions concerning the interaction partners of this channel and their 
unrecognized functions or their role in the pathophysiology of arrhythmias. The proteins 
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interacting with Nav1.5 can act as (i) anchoring proteins involved in trafficking of the 
channel to specific membrane compartments; (ii) enzymes modifying the channel 
structure via post-translational modifications; and (iii) proteins modulating biophysical 
properties of Nav1.5 upon binding [Shy et al. 2013]. Classical pharmacological inhibitors 
of cardiac sodium channels are available and can be classified into non-selective 
sodium channel blocker (Class I anti-arrhythmic drugs), mixed ion channel blocker 
(Class III anti-arrhythmic drugs) and late sodium current INaL inhibitors [Remme and 
Wilde 2014]. Class I anti-arrhythmic agents, like quinidine, lidocaine and flecainide 
inhibit peak Na+ currents, but also the late Na+ current as well as some repolarizing 
currents, like IKr [Zaza et al. 2008]. Thus, the use of these drugs is limited and 
associated with torsades de pointes arrhythmias, particularly in structurally abnormal 
hearts [Echt et al. 1991; Wang et al. 1996; Kim et al. 2010]. A mixed ion channel blocker 
is amiodarone, which blocks INaL in higher sensitivity. Amiodarone also inhibits calcium 
channels and is used for IKr block related arrhythmias, but shows serious side effects in 
a significant number of patients [Zaza et al. 2008]. A more potent late sodium current 
blocker is ranolazine [Belardinelli et al. 2006]. The late sodium current is increased in 
cardiomyocytes of patients with heart failure, which leads to a prolongation of the AP. 
Therefore, ranolazine, with its therapeutic effects of shortening AP duration and 
preventing abnormalities in the intracellular Na+/Ca+ homeostasis is used for the 
treatment of hypertrophic or failing hearts [Moreno and Clancy 2012]. However, it has to 
be acknowledged that due to the complexity and diversity of cardiac sodium channels, 
specific therapeutic targets for modulation of these channels are still limited. For a 
specific drug development, it is important to identify physiological interactions between 





1.4 Aim of the thesis and systematic approach 
 
The role of Dipeptidylpeptidase-like protein 10 (DPP10) is largely unknown, but the 
protein gained interest as accessory β-subunit of voltage-gated K+ channels in the brain 
[Jerng et al. 2004]. Here, DPP10 influence the kinetics of the transient outward K+ 
currents by accelerating the time course of activation, inactivation and recovery from 
inactivation [Radicke et al. 2005; Cotella et al. 2010]. It is known that DPP10 is part of a 
ternary complex together with Kv4 channels and other β-subunits: K+ channel 
interacting proteins (KChIPs). DPP10 is implicated in neuropsychiatric diseases, such 
as autism [Girirajan et al. 2013] and Alzheimer disease [Chen et al. 2014]. The protein 
was also observed in human atria [Cotella et al. 2010; Turnow et al. 2015], but DPP10 
expression in ventricles was not studied. Other β-subunits, like Navβ1 or KChIP2 
interact with both, voltage-gated K+ (Kv4) as well as voltage-gated Na+ channels (Nav) 
by modulating their current properties, linking these channel complexes in the heart. 
The aim of this work was to characterize the function of DPP10 as cardiac β-subunit for 
Kv and Nav channel complexes and to analyze how DPP10 affects IK, INa and the 
cardiac action potential. We first studied the modulation of the cardiac transient outward 
K+ current Ito by DPP10, using whole-cell patch clamp technique in CHO cells and 
human atrial myocytes. Expression, localization and co-localization to Kv4.3 were 
analyzed by qPCR, immunoblotting and immunostaining. The interaction of DPP10 with 
Kv1.5 and its modulation of IKur was investigated as well. A modulation of Ito by DPP10 
may affect the late repolarization phase of an atrial action potential. With a possible 
interaction of DPP10 with cardiac Kv channels, we wanted to know whether DPP10 
could also be a β-subunit for cardiac Nav channels. Therefore, we assessed DPP10 
expression in human ventricles and further investigated possible effects of DPP10 on INa 
and action potentials in ventricular myocytes. Causing the difficulties of donation, 
isolation and culture of native human ventricular cardiomyocytes, expression systems of 
heterologous CHO cells were used to study Nav1.5/DPP10 interactions. Another 
possibility was the pathological model of isolated rat cardiomyocytes with very low 
endogenous DPP10 levels in which an adenoviral gene transfer was used to 
overexpress DPP10 and to analyze physiological protein interactions and native current 
modulations with Nav1.5 and modulations in ventricular action potential. Co-
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immunoprecipitation with human ventricles could also confirm a physical interaction of 
Nav1.5 and DPP10. 
This thesis aimed to identify the cardiac accessory β-subunit DPP10 as a part of 
macromolecular K+ and Na+ channel complexes and modulator of their biophysical 
properties. The results should expand our understanding of Na+ channel or K+ channel 
regulation, which might have an important implication for the development of new 
therapeutic strategies for heart failure, atrial fibrillation and arrhythmias. 
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2 The research articles 
 
In the following, the research articles that have been published in reviewed journals are 
presented: 
- “Interaction of DPP10a with Kv4.3 channel complex results in a sustained current 
component of human transient outward current Ito” 
(Published in Basic Research in Cardiology, 2015) 
 
- “DPP10 is a new regulator of Nav1.5 channels in human heart” 
(Published in International Journal of Cardiology, 2019) 
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The action potential (AP) of each cell is generated by various ionic currents, starting 
with rapid depolarization due to a large Na+ influx (INa) into the cell via voltage-gated 
Na+ channels (Nav). The depolarization is followed by a rapid repolarization, based on 
increased conductance for K+ ions. In cardiomyocytes, the total K+ outward current (IK) 
is represented by a peak current component due to the transient outward current Ito and 
a late (sustained) current component underlying the ultra-rapidly activating (delayed) 
rectifier IKur. Both currents are conducted via voltage-gated K+ channel (Kv). The 
molecular constituent of Ito is Kv4.3, whereas IKur correlates with Kv1.5. Because of their 
overlap in time and voltage dependence, Ito and IKur are difficult to separate. The 
waveform of action potentials differs within the different regions of the heart, reflecting 
that the underlying ion channels have different expression levels in the atrium and 
ventricle, as well as in epicardium, myocardium and endocardium. The α-subunit of K+ 
and Na+ channels additionally interacts with several β-subunits. Cardiac accessory β-
subunits are part of macromolecular ion channel complexes and modulate the 
electrophysiological properties of resulting ion currents. Mutations or changes in 
expression of β-subunits are associated with cardiac disease, such as arrhythmias.  
We studied DPP10 (dipeptidyl peptidase-like protein 10) as a transmembrane β-subunit 
of cardiac Na+ and K+ channels, linking these channel complexes in the heart. DPP10 
belongs to the prolyl-oligopeptidase family of serine proteases, but it lacks the 
exopeptidase activity. The role of DPP10 was largely unknown but the protein gained 
interest as accessory β-subunits of Kv4.2 in the brain. Recent studies revealed that 
DPP10 modulates the voltage-dependence and the kinetics of the expressed Kv4.2 
channels in heterologous expression systems accelerating the time course of activation, 
inactivation and recovery from inactivation. It is known that DPP10 is part of a ternary 
complex together with Kv4 channels and other β-subunits: K+ channel interacting 
proteins (KChIPs). The aim of the work presented here was to characterize the 
functions of DPP10 as a cardiac β-subunit for Kv and Nav channel complexes and to 
analyze how DPP10 affects IK, INa and the cardiac action potential.  
In the present study, we first investigated whether DPP10 modulates the kinetics of 
cardiac K+ outward currents in CHO cells and human atrial myocytes. DPP10 
expression was analyzed, using qPCR, immunoblotting and immunostaining. Three 
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different mRNA splice variants of DPP10 (DPP10a, c, d) could be detected in lysates of 
human atria and brain. Co-localization of DPP10 and Kv4.3 in isolated human atrial 
myocytes was confirmed by co-immunostaining. Electrophysiological experiments, 
using the whole-cell voltage clamp technique, revealed that DPP10 modulates Ito 
currents in CHO cells co-expressing DPP10 with Kv4.3 and KChIP2, by accelerating the 
time course of activation, inactivation and recovery from inactivation. Interestingly, 
DPP10 induces an Ito late current component in these cells, which was not observed in 
cells co-expressing Kv4.3/KChIP2 and the family member DPP6. Since the sustained 
K+ outward current component is known to be generated by Kv1.5 channels, we studied 
a possible interaction of Kv1.5 with DPP10. In the heterologous expression system, we 
could not detect any interaction between DPP10 and Kv1.5 channel underlying the 
sustained K+ current IKur. To study the contribution of DPP10-induced late current 
component on the sustained K+ outward current in human atrial myocytes, cardiac 
tissue samples were obtained from right atrial appendages of patients undergoing open-
heart surgery, and myocytes were isolated enzymatically for patch clamp 
measurements. Using a pharmacological approach with 4-Aminopyridine to block IKur in 
combination with Heteropoda toxin 2 to inhibit Ito conducted via Kv4 channels, we were 
able to separate an Ito fraction of about 19% contributing to the late current component. 
Thus, the generation of this sustained Ito current component generated by DPP10 may 
affect the late repolarization phase of the atrial action potential. Therefore, DPP10 may 
contribute to the decrease of the action potential duration (APD), which is observed in 
atrial fibrillation. Selective inhibition of currents contributing to the late AP repolarization 
might expand the APD and represent a strategy for the treatment of atrial fibrillation. 
Due to the expression of DPP10 in human atrium and electrophysiological modulation of 
Ito, DPP10 might be a potential target for novel antiarrhythmic drugs, especially for the 
treatment of atrial fibrillation. 
In a second part of this study, we focused on the interaction of DPP10 with Nav 
channels. Previous studies revealed that β-subunits such as Navβ1 not only interact 
with Nav channel complexes, but also with Kv4.3, thereby modulating Ito. Increased 
Navβ1 levels have been identified in patients with Brugada syndrome, atrial fibrillation 
or cardiac conduction disease. However, the role DPP10 in the interaction between K+ 
channel and Na+ channel complexes and their impact on cardiac diseases is poorly 
understood. Therefore, we assessed DPP10 expression in healthy and diseased heart 
tissue. Interestingly, significantly increased DPP10 protein levels were observed in 
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ventricles from patients with heart failure compared to healthy donors. To investigate the 
effect of DPP10 on cardiac action potential and Na+ current kinetics in native cells, we 
expressed DPP10 using adenovirus gene-transfer in rat epicardial myocytes, which 
have very low levels of endogenous DPP10. Two days after infection with the 
recombinant adenoviruses, we recorded APs from rat ventricular cardiomyocytes 
expressing DPP10 or GFP (control) using whole-cell current-clamp technique. DPP10 
expression significantly decreased the AP upstroke velocity, pointing to a modulation of 
Nav1.5 channels. Resting membrane potential, AP amplitude and duration were not 
affected by DPP10 expression. INa density between -45 mV and -35 mV was 
significantly reduced by DPP10ad, indicating an effect on Nav channel activation. 
Interestingly, the voltage-dependence of INa activation and inactivation was significantly 
shifted (by ~5 and 6 mV) to more positive voltages with DPP10 expression compared to 
controls, resulting in higher availability of Na+ channels for activation, along with an 
increased window current. The physical interaction of hDPP10 with hNav1.5 channels 
was confirmed using co-immunoprecipitation experiments in transfected CHO cells co-
expressing Nav1.5 and DPP10. Notably, patch clamp experiments in these cells 
showed similar effects of DPP10 on INa properties as observed in rat cardiomyocytes. 
Moreover, DPP10 co-immunoprecipitated with Nav1.5 in protein lysates from human 
ventricles, confirming their physical interaction also in human heart. In summary, we 
identified DPP10 as a novel regulator of Nav1.5 bearing cardiac Na+ channels in 
addition to Kv4 channels. These novel findings expand our understanding of Na+ 
channel regulation, which might have important implications for the development of new 
therapeutic strategies for heart failure and arrhythmias. 




Das Herz kontrolliert die Blutzirkulation und versorgt dadurch den gesamten 
menschlichen Körper mit Sauerstoff und Nährstoffen. Gewährleistet wird dies durch 
eine rhythmische Kontraktion der Herzmuskulatur, welche durch elektrische Erregung 
und Weiterleitung entsteht. Die Entstehung von kardialen Aktionspotenzialen ist dabei 
von großer Bedeutung. Die Basis der Erregung stellt das Ruhemembranpotenzial der 
Kardiomyozyten dar, welches hauptsächlich durch die unterschiedliche Verteilung und 
Permeabilität von Na+ und K+ Ionen zwischen extra- und intrazellulären Raum aufrecht 
gehalten wird. Verschiedene Ionenströme sorgen für die Ausbildung und Form des 
kardialen Aktionspotenzials (AP). Der Na+ Einstrom in die Zelle (INa), bedingt durch die 
Aktivierung von spannungsabhängigen Na+ Kanälen (Nav), sorgt für eine schnelle 
Depolarisation, gefolgt von einer schnellen, frühen Repolarisation zu Beginn des 
kardialen AP. Diese ist gekennzeichnet durch eine verstärkte Leitfähigkeit von K+ Ionen. 
Der totale K+ Auswärtsstrom der Kardiomyozyte (IK) besteht aus einem Spitzenstrom 
und einer späten, nicht-inaktivierbaren Komponente. In der Literatur wird der 
Spitzenstrom dem transienten Auswärtsstrom Ito zugeordnet, der durch den Kv4.3 
Kanalkomplex generiert wird. Der IKur hingegen, generiert durch den Kv1.5 
Kanalkomplex, ist ein weiterer K+ Auswärtsstrom in Vorhofmyozyten und wird der 
späten, nicht-inaktivierbaren Stromkomponente zugeordnet. Ionenkanäle sind in den 
unterschiedlichen Regionen des Herzens (z.B. in Vorhof und Ventrikel) unterschiedlich 
stark exprimiert und bedingen die unterschiedliche Form des AP in verschiedenen 
Herzregionen. Die porenbildenden α-Untereinheiten von K+ und Na+ Kanälen 
interagieren zusätzlich mit akzessorischen β-Untereinheiten. Kardiale β-Untereinheiten 
sind meist Bestandteil von makromolekularen Ionenkanalkomplexen und können die 
elektrophysiologischen Eigenschaften der Kanäle und deren Ionenströme modulieren. 
Mutationen oder Veränderungen in der Expression von β-Untereinheiten sind an der 
Entstehung von Herzerkrankungen und Arrhythmien beteiligt. Im Rahmen dieser Arbeit 
sollte die Funktion der β-Untereinheit DPP10 (Dipeptidylpeptidase-ähnliches Protein 10) 
im Herzen untersucht werden. 
Dabei konnten wir DPP10 als eine akzessorische β-Untereinheit sowohl von Na+ als 
auch von K+ Kanälen identifizieren. DPP10 gehört strukturell zur Familie der 
Serinproteasen, allerdings fehlt dem Protein die Exopeptidase-Aktivität durch eine 
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Substitution im enzymatischen Zentrum. DPP10 war bislang als β-Untereinheit von Kv4 
Kanälen im Gehirn bekannt. Ziel dieser Arbeit war es, die Expression und Interaktion 
von DPP10 mit kardialen Na+ und K+ Kanalkomplexen und dessen Effekt auf die 
resultierenden Ionenströme (IK und INa) und Aktionspotenziale im Herzen zu 
untersuchen. 
In der vorliegenden Arbeit wurde zunächst die Expression im humanen Vorhof und die 
Modulation von K+-Auswärtsströmen durch DPP10 charakterisiert. Hierfür wurden 
humane Vorhofmyozyten, sowie ein heterologes Expressionssystem (CHO Zellen) 
genutzt. Die Expression von DPP10 wurde mittels qPCR, Immunblot und Immunfärbung 
überprüft. Das Protein wurde in Lysaten von humanen Vorhofgewebe und im Gehirn 
detektiert. Drei mRNA Splice-Varianten (DP10a, c, d) wurden identifiziert. Die 
Immunfärbung zeigte eine Kolokalisation von DPP10 mit Kv4.3 in isolierten, humanen 
Vorhofmyozyten. In elektrophysiologischen Experimenten konnte mittels Patch-Clamp 
Messungen gezeigt werden, dass DPP10 den Ito moduliert. In CHO Zellen, welche 
Kv4.3 und die zytosolische β-Untereinheit KChIP2 koexpremieren, konnte gezeigt 
werden, dass die Ito Stromdichte, sowie der Zeitverlauf der Aktivierung, Inaktivierung 
und der Erholung von der Inaktivierung mit zusätzlicher Expression von DPP10 
beschleunigt waren. Interessanterweise generierte DPP10 in diesen Zellen eine späte, 
nicht-inaktivierbare Komponente des Ito, welche bei Koexpression von DPP6 nicht 
beobachtet wurde. Da die späte, nicht-inaktivierbare K+-Stromkomponente den Kv1.5 
Kanälen zugeordnet wird, wurde hier die mögliche Interaktion von DPP10 und Kv1.5 
untersucht. Im heterologen Expressionssystem wurde keine Interaktion zwischen dem 
IKur bildenden Kv1.5 und DPP10 beobachtet. Um zu prüfen, welchen Anteil die DPP10-
induzierte späte Ito Komponente am nicht-inaktivierbaren IK in humanen Vorhofzellen 
hat, wurde Herzgewebe bei Patienten während einer Operation am offenen Herzen 
entnommen. Für die Patch-Clamp Messungen wurden anschließend Kardiomyozyten 
durch enzymatischen Verdau mit Kollagenase isoliert. Ein pharmakologischer Ansatz 
wurde genutzt, um den Ito Anteil vom gesamten IK zu identifizieren. Zuerst erfolgte die 
Hemmung des IKur durch 4-Aminopyridin und dann die Blockade des Ito mit Heteropoda 
toxin 2. Es war somit möglich einen bisher unbekannten Anteil des Ito von 19% am 
späten, nicht-inaktivierbaren Kaliumstrom in humanen Vorhofmyozyten zu separieren. 
Dieser Anteil des Ito entsteht vermutlich durch den Einfluss der β-Untereinheit DPP10 
und könnte zu den Veränderungen der späten Repolarisationsphase im 
Aktionspotenzial mit Verlängerung der Aktionspotentialdauer (APD) bei Vorhofflimmern 
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beitragen. Da DPP10 im humanen Vorhof exprimiert ist und dort den Ito physiologisch 
moduliert, könnte diese β-Untereinheit einen interessanten Angriffspunkt für die 
Entwicklung neuer Antiarrhythmika darstellen, insbesondere für die Behandlung des 
Vorhofflimmerns. 
Im zweiten Teil dieser Arbeit untersuchten wir die Interaktion von DPP10 mit Nav 
Kanälen. Es konnte in Studien gezeigt werden, dass β-Untereinheiten, wie Navβ1, nicht 
nur mit Nav1.5, sondern auch mit Kv4.3 interagieren und den Ito modulieren. Eine 
erhöhte Expression von Navβ1 im Herzen wurde in Patienten mit Brugada Syndrom, 
Vorhofflimmern und Erregungsleitungsstörung gefunden. Die Bedeutung der β-
Untereinheit DPP10 an der Entstehung von Herzkrankheiten bzw. der Interaktion 
zwischen K+ und Na+ Kanalkomplexen ist bisher noch nicht geklärt. Wir konnten zeigen, 
dass die Expression von DPP10 in Ventrikelgewebe von Patienten mit Herzinsuffizienz 
signifikant erhöht ist. Um den Einfluss von DPP10 auf das kardiale Aktionspotenzial 
sowie den Ito und INa in nativen Zellen zu untersuchen, exprimierten wir DPP10 mittels 
adenoviralem Gentransfer in isolierten epikardiale Kardiomyozyten der Ratte, welche 
eine sehr schwache, endogene DPP10 Expression aufwiesen. Die Kardiomyozyten 
wurden nach der Isolation mit dem DPP10-kodierenden rekombinanten Adenovirus 
infiziert und nach 2 Tagen in Kultur konnte die Expression von DPP10 nachgewiesen 
und Aktionspotenziale mittels Patch-Clamp Technik gemessen werden. Bei 
Überexpression von DPP10 war die Aufstrichgeschwindigkeit des Aktionspotenzials 
gegenüber Kontrollzellen signifikant reduziert, was erstmals auf eine Interaktion mit 
kardialen Nav-Kanälen hinwies. Ruhemembranpotenzial, AP-Amplitude und APD waren 
durch DPP10 nicht beeinflusst. DPP10 verminderte signifikant die INa Stromdichte 
zwischen Membranpotenzialen von -45 mV und -35 mV, was wiederum auf die 
Modulation der Spannungsabhängigkeit der Kanäle hindeutete. Interessanterweise 
wurde auch die Spannungsabhängigkeit der Aktivierung und Inaktivierung durch DPP10 
Expression signifikant um etwa 5-6 mV zu positiveren Spannungen verschoben, die 
eine erhöhte Verfügbarkeit von Natriumkanälen bedingte. Die biochemische Interaktion 
von humanen DPP10 und humanen Nav1.5 Proteinen wurde mittels Ko-
Immunopräzipitation in transfizierten CHO-Zellen nachgewiesen. In Patch-Clamp 
Experimenten wurden ähnliche INa Stromeigenschaften bei Koexpression von Nav1.5 
und DPP10 beobachtet wie im Modell der Rattenmyozyten. Die Ko-Immunopräzipitation 
von DPP10 mit Nav1.5 in Lysaten von humanem Ventrikelgewebe untermauert den 
Nachweis einer physikalischen Interaktion beider Untereinheiten in vivo. 
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Zusammenfassend konnten wir erstmals DPP10 als neuen Regulator Nav1.5 im Herzen 
identifizieren. Hier könnte ein Zusammenhang zwischen der erhöhten DPP10 
Expression und der Entstehung der Arrhythmien bei Herzinsuffizienz bestehen. Die 
Erkenntnisse dieser Arbeit über die Regulation von Natrium- und Kaliumkanälen durch 
die β-Untereinheiten könnten unter anderem Auswirkungen auf die Entwicklung neuer 
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AP   Action potential 
4-AP    4-Aminopyridine 
APD   Action potential duration 
CHO   Chinese hamster ovary 
DPP   Dipeptidylpetidase(-like) proteins 
HEK   Human embryonic kidney 
HPTX2   Heteropoda toxin 2 
ICa,L   L-type Ca2+ current (inward) 
IK1   Cardiac inward rectifier K+ current 1 
IK,ACh   Acetylcholine dependent K+ current (inward rectifier) 
IKr   Rapidly activating delayed rectifier K+ current (outward) 
IKs   Slowly activating delayed rectifier K+ current (outward) 
IKur   Ultra-rapid K+ current (outward) 
INa   Na+ current (inward) 
INCX   Current of the Na+-Ca2+ exchanger 
Ito   Transient K+ outward current 
KChAP   K+ channel associated protein 
KChIP  K+ channel interacting protein 
KCNX   Gene encoding voltage gated, shaker related K+ channel member X 
Kv   Voltage-gated K+ channel 
Nav   Voltage-gated Na+ channel 
SCNXA  Gene encoding voltage gated Na+ channel member X 
TTX   Tetrodotoxin 
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